Rtw Investments, LP Acadia Pharmaceuticals Inc Transaction History
Rtw Investments, LP
- $6.27 Billion
- Q3 2024
A detailed history of Rtw Investments, LP transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Rtw Investments, LP holds 13,707,506 shares of ACAD stock, worth $235 Million. This represents 3.36% of its overall portfolio holdings.
Number of Shares
13,707,506
Previous 13,707,506
-0.0%
Holding current value
$235 Million
Previous $223 Million
5.29%
% of portfolio
3.36%
Previous 3.72%
Shares
8 transactions
Others Institutions Holding ACAD
# of Institutions
279Shares Held
156MCall Options Held
901KPut Options Held
314K-
Baker Bros. Advisors LP New York, NY42.9MShares$736 Million7.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.8MShares$238 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$207 Million0.0% of portfolio
-
State Street Corp Boston, MA5.97MShares$103 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.5MShares$60.2 Million0.05% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.78B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...